Page last updated: 2024-09-05

adenosine-5'-o-(beta,gamma-dichloromethane)triphosphate and Bone Loss, Osteoclastic

adenosine-5'-o-(beta,gamma-dichloromethane)triphosphate has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Auriola, S; Frith, JC; Mönkkönen, H; Mönkkönen, J; Rogers, MJ1

Other Studies

1 other study(ies) available for adenosine-5'-o-(beta,gamma-dichloromethane)triphosphate and Bone Loss, Osteoclastic

ArticleYear
The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis.
    Arthritis and rheumatism, 2001, Volume: 44, Issue:9

    Topics: Adenosine Triphosphate; Alendronate; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents; Apoptosis; Bone Resorption; Capsules; Cells, Cultured; Clodronic Acid; Liposomes; Macrophages, Peritoneal; Osteoclasts; Protein Prenylation; Rabbits; rap1 GTP-Binding Proteins; Rats; Rats, Sprague-Dawley

2001